In March 2025, the FDA approved Sanofi/Alnylam Pharmaceuticals Qfitlia (fitusiran), an RNAi therapeutic to prevent or reduce the frequency of bleeding episodes in adult and paediatric patients (aged 12 years of age and over) with haemophilia A or B, with or without factor VIII or IX inhibitors
This syringe includes a passive needle retraction feature that eliminates the need to recap, reducing exposure and further lowering contamination risks
Zeiger, A
Despite concerns that the indole nitrogen would be susceptible to attack by tert -butyl cation generated upon Boc-group cleavage, we found that protection of indole nitrogen in tryptophan could be omitted from this process without substantial deterioration of the product yield or purity
Its liquid format ensures ease of use and fast absorption, making it suitable before training, during increased activity, or at any time of day when additional metabolic support is desired
A study indicated that melatonin could be a candidate for neuroprotection in ALS (Jacob et al., 2002)
